Stablepoint Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Buy |
20,066
+1,268
| +7% | +$87.5K | 0.24% | 128 |
|
|
2025
Q1 | $1.31M | Buy |
18,798
+6,730
| +56% | +$467K | 0.24% | 124 |
|
|
2024
Q4 | $1.04M | Buy |
12,068
+600
| +5% | +$51.6K | 0.19% | 138 |
|
|
2024
Q3 | $1.37M | Sell |
11,468
-68
| -0.6% | -$8.1K | 0.25% | 116 |
|
|
2024
Q2 | $1.48M | Sell |
11,536
-2,474
| -18% | -$317K | 0.29% | 102 |
|
|
2024
Q1 | $1.8M | Buy |
14,010
+1,419
| +11% | +$182K | 0.36% | 85 |
|
|
2023
Q4 | $1.3M | Buy |
+12,591
| New | +$1.3M | 0.33% | 86 |
|